MD
MDLN
Market ClosedMedline Inc.
US
43.00K employees
CEO: James Boyle
Founded: 2025
$43.19
+$0.00(+NaN%)
Market Cap
36.52B
Beta
-0.42
52W Range
N/A
Dividend Yield
0.00%
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
26.4%
19.5%
CAGR: 18.2%
Profit after direct costs
Operating Margin
7.8%
-0.6%
CAGR: 36.5%
Core business profitability
Net Margin
4.1%
-3.4%
CAGR: N/A
Bottom line profitability
Revenue Growth
11.5%
YoY
CAGR: 9.9%
Top line growth rate
Revenue Flow Analysis
Visual flow showing how MDLN allocates revenue across expenses and profit
Fiscal Year Latest
Revenue Distribution
Flow of revenue through cost categories to net income
Gross Margin
26.4%
$7.52B
Operating Margin
7.8%
$2.21B
Net Margin
4.1%
$1.16B
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
| Item | Trend | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|
Total Revenue | 21.45B | 23.23B | 25.51B | 28.43B | 11.5% | |
| Cost of Revenue | (16.89B) | (18.01B) | (19.22B) | (20.91B) | 8.8% | |
Gross Profit | 4.56B | 5.22B | 6.29B | 7.52B | 19.5% | |
| Operating Expenses | ||||||
| Research & Development | (58.00M) | (60.00M) | (67.00M) | — | -100.0% | |
| Selling, General & Administrative | (3.62B) | (3.81B) | (4.04B) | (4.52B) | 12.0% | |
| Depreciation & Amortization | (933.00M) | (951.00M) | (977.00M) | (704.00M) | -27.9% | |
Operating Income (EBIT) | 870.00M | 1.44B | 2.23B | 2.21B | -0.6% | |
| Non-Operating Items | ||||||
| Interest Income | 27.00M | 237.00M | 280.00M | — | -100.0% | |
| Interest Expense | (911.00M) | (1.38B) | (1.31B) | (812.00M) | -38.0% | |
| Other Income/Expenses (Net) | -860.00M | -1.18B | -979.00M | -964.00M | -1.5% | |
Income Before Tax | 10.00M | 264.00M | 1.25B | 1.25B | 0.2% | |
| Income Tax Expense | (35.00M) | (30.00M) | (46.00M) | (91.00M) | 97.8% | |
Net Income | -25.00M | 234.00M | 1.20B | 1.16B | -3.4% | |
| Per Share Metrics | ||||||
| Earnings Per Share (Basic) | $-0 | $0 | $2 | $1 | -5.9% | |
| Weighted Avg Shares Outstanding | 787.12M | 787.12M | 787.12M | 812.00M | 3.2% | |
| Weighted Avg Shares Outstanding (Diluted) | 787.12M | 787.12M | 787.12M | 812.00M | 3.2% | |
EBITDA | 1.85B | 2.59B | 3.53B | 1.95B | -44.7% |
Explore MDLN
MDLN in the Healthcare
Large Cap